Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fate Therapeutics
Actuate Therapeutics Inc.
AstraZeneca
AbbVie
Incyte Corporation
First Affiliated Hospital of Zhejiang University
Jazz Pharmaceuticals
Eli Lilly and Company
Sun Yat-sen University
Philogen S.p.A.
AIDS Malignancy Consortium
Gilead Sciences
Oncology Institute of Southern Switzerland
AbbVie
University of California, San Francisco
National Cancer Institute (NCI)
Amgen
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey